Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EN001 in Charcot-Marie-Tooth Disease Type 1A
NCT06328712Phase 2Recruiting
- Sponsor
- ENCell
- Start
- May 2024
- Primary completion
- Dec 2026
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of EN001 in Charcot-Marie-Tooth disease type 1A (CMT1A), sponsored by ENCell. Started May 2024; status: recruiting.
02
Drugs
EN001
03
Conditions
Charcot-Marie-Tooth disease type 1A (CMT1A)
Beyond the preview
Go deeper on NCT06328712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06328712.